US Patent 11865148 Methods of delivering transgenes to the eye
Patent 11865148 was granted and assigned to Krystal Biotech on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+31 properties)
Article (+444 characters)
US Patent 11865148 Methods of delivering transgenes to the eye
Article
Patent abstract
Provided herein are methods of delivering transgenes to an eye of a subject comprising the use of pharmaceutical compositions having one or more polynucleotides suitable for enhancing, increasing, augmenting, and/or supplementing the levels of the transgene in the eye. Also provided herein are methods of correcting vision loss in a subject in need thereof comprising the use of the pharmaceutical compositions described herein.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Suma Krishnan0
Date of Patent
January 9, 2024
0Patent Application Number
180605150
Date Filed
November 30, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11865148 Methods of delivering transgenes to the eye
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.